Biocon Limited (NSE:BIOCON)
417.60
+15.15 (3.76%)
May 13, 2026, 3:29 PM IST
Biocon Revenue
Biocon had revenue of 41.73B INR in the quarter ending December 31, 2025, with 9.20% growth. This brings the company's revenue in the last twelve months to 168.27B, up 13.99% year-over-year. In the fiscal year ending March 31, 2025, Biocon had annual revenue of 152.62B with 3.43% growth.
Revenue (ttm)
168.27B
Revenue Growth
+13.99%
P/S Ratio
3.87
Revenue / Employee
10.25M
Employees
16,420
Market Cap
651.31B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 152.62B | 5.06B | 3.43% |
| Mar 31, 2024 | 147.56B | 35.82B | 32.05% |
| Mar 31, 2023 | 111.74B | 29.90B | 36.54% |
| Mar 31, 2022 | 81.84B | 10.41B | 14.57% |
| Mar 31, 2021 | 71.43B | 8.43B | 13.37% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Dishman Carbogen Amcis | 27.97B |
| Anthem Biosciences | 20.02B |
| OneSource Specialty Pharma | 14.19B |
| Concord Biotech | 11.59B |
| Blue Jet Healthcare | 10.53B |
| Supriya Lifescience | 7.35B |
| Panacea Biotec | 6.06B |
| Zota Health Care | 4.73B |
Biocon News
- 13 hours ago - Pharma Stocks Today, May 13: Wockhardt rises 1.97%, Orchid Pharma falls 1.79%, Biocon gains 1.38% - Business Upturn
- 1 day ago - Top gainers today: oil India at ₹490.95 up 7.66%, ONGC at ₹294.50 up 4.80%, biocon at ₹402.45 up 3.07% - Business Upturn
- 1 day ago - Pharma sector stocks fall today, May 12: Orchid Pharma falls 3.74%, J.B. Chemicals down 2.67%, Biocon rises 0.79% - Business Upturn
- 2 days ago - Pharma Stocks Today, May 11: Torrent Pharma up 3.77%, Lupin falls 4.50%, Biocon rises 3.36% - Business Upturn
- 2 days ago - Biocon Pharma receives Health Canada approval for micafungin injection - Business Upturn
- 4 days ago - Biocon Ltd (BOM:532523) Full Year 2026 Earnings Call Highlights: Strong Biosimilars Growth and ... - GuruFocus
- 4 days ago - Full Year 2026 Biocon Ltd Earnings Call Transcript - GuruFocus
- 5 days ago - Biocon Earnings Call Transcript: Q4 2026 - Transcripts